company background image
PSG

PharmaSGP Holding XTRA:PSG Stock Report

Last Price

€18.70

Market Cap

€224.4m

7D

-0.3%

1Y

-26.7%

Updated

07 Dec, 2023

Data

Company Financials +

PSG Stock Overview

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany.

PSG fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance4/6
Financial Health3/6
Dividends3/6

PharmaSGP Holding SE Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PharmaSGP Holding
Historical stock prices
Current Share Price€18.70
52 Week High€29.60
52 Week Low€17.70
Beta-0.026
1 Month Change-6.50%
3 Month Change-20.76%
1 Year Change-26.67%
3 Year Change-15.77%
5 Year Changen/a
Change since IPO-45.80%

Recent News & Updates

Recent updates

PharmaSGP Holding SE Just Beat Revenue Estimates By 25%

Dec 02
PharmaSGP Holding SE Just Beat Revenue Estimates By 25%

One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically

Feb 16
One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically

We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential

Jan 26
We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential

Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?

Dec 04
Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?

Shareholder Returns

PSGDE PharmaceuticalsDE Market
7D-0.3%-6.7%1.9%
1Y-26.7%-26.5%5.7%

Return vs Industry: PSG matched the German Pharmaceuticals industry which returned -26.5% over the past year.

Return vs Market: PSG underperformed the German Market which returned 5.7% over the past year.

Price Volatility

Is PSG's price volatile compared to industry and market?
PSG volatility
PSG Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement5.0%
10% most volatile stocks in DE Market9.4%
10% least volatile stocks in DE Market2.3%

Stable Share Price: PSG is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: PSG's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201285Natalie Weigandhttps://pharmasgp.com

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company’s pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for treatment of hair loss; Dorisol, a pain relies tablet; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels. It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten, for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness and mood swings; Deruba, a cream for skin redness; Lentisol prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo.

PharmaSGP Holding SE Fundamentals Summary

How do PharmaSGP Holding's earnings and revenue compare to its market cap?
PSG fundamental statistics
Market Cap€224.40m
Earnings (TTM)€14.99m
Revenue (TTM)€97.55m

15.0x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PSG income statement (TTM)
Revenue€97.55m
Cost of Revenue€9.16m
Gross Profit€88.40m
Other Expenses€73.41m
Earnings€14.99m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.25
Gross Margin90.61%
Net Profit Margin15.37%
Debt/Equity Ratio210.6%

How did PSG perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

39%

Payout Ratio